
NanoString Technologies NSTG
Quarterly report 2023-Q3
added 11-06-2023
NanoString Technologies P/E Ratio 2011-2026 | NSTG
Annual P/E Ratio NanoString Technologies
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.88 | -13.9 | -24.8 | -23.8 | -7.83 | -4.34 | -7.55 | -5.82 | -4.48 | -4.83 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.88 | -24.8 | -10 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 21.94 | 2.48 % | $ 1.03 B | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-4.91 | $ 0.9 | 0.49 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
14.1 | $ 22.66 | 3.19 % | $ 3.76 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.136 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 102.75 | -2.57 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
-0.0467 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.14 | 1.35 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 23.58 | 1.38 % | $ 3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.44 | -0.35 % | $ 383 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 2.92 | -0.45 % | $ 4.81 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | ||
|
ContraFect Corporation
CFRX
|
-0.0166 | - | -5.16 % | $ 5.39 M | ||
|
Cardiff Oncology
CRDF
|
-2.54 | $ 1.72 | - | $ 115 M | ||
|
BioXcel Therapeutics
BTAI
|
-0.22 | $ 1.1 | 3.77 % | $ 13.4 M | ||
|
Cabaletta Bio
CABA
|
-1.69 | $ 2.99 | 1.19 % | $ 300 M | ||
|
Cara Therapeutics
CARA
|
-0.457 | - | -3.03 % | $ 260 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
CASI Pharmaceuticals
CASI
|
-29.7 | - | - | $ 35.4 M | ||
|
CymaBay Therapeutics
CBAY
|
-32.5 | - | - | $ 3.45 B |